These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 15827571)

  • 61. Endogenous regulators of G protein signaling differentially modulate full and partial mu-opioid agonists at adenylyl cyclase as predicted by a collision coupling model.
    Clark MJ; Linderman JJ; Traynor JR
    Mol Pharmacol; 2008 May; 73(5):1538-48. PubMed ID: 18285510
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Mu-opioid receptor desensitization by beta-arrestin-2 determines morphine tolerance but not dependence.
    Bohn LM; Gainetdinov RR; Lin FT; Lefkowitz RJ; Caron MG
    Nature; 2000 Dec; 408(6813):720-3. PubMed ID: 11130073
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Analgesic tolerance to high-efficacy agonists but not to morphine is diminished in phosphorylation-deficient S375A μ-opioid receptor knock-in mice.
    Grecksch G; Just S; Pierstorff C; Imhof AK; Glück L; Doll C; Lupp A; Becker A; Koch T; Stumm R; Höllt V; Schulz S
    J Neurosci; 2011 Sep; 31(39):13890-6. PubMed ID: 21957251
    [TBL] [Abstract][Full Text] [Related]  

  • 64. G-protein antisense oligodeoxyribonucleotides and mu-opioid supraspinal antinociception.
    Raffa RB; Martinez RP; Connelly CD
    Eur J Pharmacol; 1994 Jun; 258(1-2):R5-7. PubMed ID: 7925586
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Gz mediates the long-lasting desensitization of brain CB1 receptors and is essential for cross-tolerance with morphine.
    Garzón J; de la Torre-Madrid E; Rodríguez-Muñoz M; Vicente-Sánchez A; Sánchez-Blázquez P
    Mol Pain; 2009 Mar; 5():11. PubMed ID: 19284549
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Mu-opioid receptors transiently activate the Akt-nNOS pathway to produce sustained potentiation of PKC-mediated NMDAR-CaMKII signaling.
    Sánchez-Blázquez P; Rodríguez-Muñoz M; Garzón J
    PLoS One; 2010 Jun; 5(6):e11278. PubMed ID: 20585660
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Mechanisms involved in morphine-induced activation of synaptosomal Na+,K+-ATPase.
    Masocha W; González LG; Baeyens JM; Agil A
    Brain Res; 2002 Dec; 957(2):311-9. PubMed ID: 12445973
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Agonists determine the pattern of G-protein activation in mu-opioid receptor-mediated supraspinal analgesia.
    Sánchez-Blázquez P; Gómez-Serranillos P; Garzón J
    Brain Res Bull; 2001 Jan; 54(2):229-35. PubMed ID: 11275413
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Role of the guanine nucleotide binding protein, Gα
    Lamberts JT; Rosenthal LD; Jutkiewicz EM; Traynor JR
    Psychopharmacology (Berl); 2018 Jan; 235(1):71-82. PubMed ID: 28971229
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Mu-opioid receptor mRNA regulation during morphine tolerance in the rat peripheral nervous system.
    Meuser T; Giesecke T; Gabriel A; Horsch M; Sabatowski R; Hescheler J; Grond S; Palmer PP
    Anesth Analg; 2003 Nov; 97(5):1458-1463. PubMed ID: 14570665
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The σ1 receptor engages the redox-regulated HINT1 protein to bring opioid analgesia under NMDA receptor negative control.
    Rodríguez-Muñoz M; Sánchez-Blázquez P; Herrero-Labrador R; Martínez-Murillo R; Merlos M; Vela JM; Garzón J
    Antioxid Redox Signal; 2015 Apr; 22(10):799-818. PubMed ID: 25557043
    [TBL] [Abstract][Full Text] [Related]  

  • 72. High-resolution structure of RGS17 suggests a role for Ca
    Sieng M; Hayes MP; O'Brien JB; Andrew Fowler C; Houtman JC; Roman DL; Lyon AM
    J Biol Chem; 2019 May; 294(20):8148-8160. PubMed ID: 30940727
    [TBL] [Abstract][Full Text] [Related]  

  • 73. SUMO-SIM interactions regulate the activity of RGSZ2 proteins.
    Garzón J; Rodríguez-Muñoz M; Vicente-Sánchez A; García-López MÁ; Martínez-Murillo R; Fischer T; Sánchez-Blázquez P
    PLoS One; 2011; 6(12):e28557. PubMed ID: 22163035
    [TBL] [Abstract][Full Text] [Related]  

  • 74. RGS9-2 is a negative modulator of mu-opioid receptor function.
    Psifogeorgou K; Papakosta P; Russo SJ; Neve RL; Kardassis D; Gold SJ; Zachariou V
    J Neurochem; 2007 Oct; 103(2):617-25. PubMed ID: 17725581
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Regulation of opioid tolerance by let-7 family microRNA targeting the mu opioid receptor.
    He Y; Yang C; Kirkmire CM; Wang ZJ
    J Neurosci; 2010 Jul; 30(30):10251-8. PubMed ID: 20668208
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The interaction of the mu-opioid receptor and G protein is altered after chronic morphine treatment in rats.
    Tao PL; Lee CR; Law PY; Loh HH
    Naunyn Schmiedebergs Arch Pharmacol; 1993 Nov; 348(5):504-8. PubMed ID: 8114950
    [TBL] [Abstract][Full Text] [Related]  

  • 77. RGS9-2 modulates nociceptive behaviour and opioid-mediated synaptic transmission in the spinal dorsal horn.
    Papachatzaki MM; Antal Z; Terzi D; Szücs P; Zachariou V; Antal M
    Neurosci Lett; 2011 Aug; 501(1):31-4. PubMed ID: 21741448
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Brain region specific actions of regulator of G protein signaling 4 oppose morphine reward and dependence but promote analgesia.
    Han MH; Renthal W; Ring RH; Rahman Z; Psifogeorgou K; Howland D; Birnbaum S; Young K; Neve R; Nestler EJ; Zachariou V
    Biol Psychiatry; 2010 Apr; 67(8):761-9. PubMed ID: 19914603
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Activation of P2X7 receptors in the midbrain periaqueductal gray of rats facilitates morphine tolerance.
    Xiao Z; Li YY; Sun MJ
    Pharmacol Biochem Behav; 2015 Aug; 135():145-53. PubMed ID: 26054441
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Modulation of immunoreactive protein kinase C-alpha and beta isoforms and G proteins by acute and chronic treatments with morphine and other opiate drugs in rat brain.
    Ventayol P; Busquets X; Garcia-Sevilla JA
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Apr; 355(4):491-500. PubMed ID: 9109366
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.